Results 181 to 190 of about 51,881 (280)

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 669-672, June 2026.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge   +5 more
wiley   +1 more source

Acute Rheumatic Fever in a Low Prevalence Setting. [PDF]

open access: yesJACC Case Rep
Coyle M   +6 more
europepmc   +1 more source

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang   +3 more
wiley   +1 more source

The Impact of Acute Rheumatic Fever Diagnosis on Rheumatic Heart Disease Severity. [PDF]

open access: yesGlob Heart
Williamson JM   +7 more
europepmc   +1 more source

Pedunculoside Inhibits Hepatocellular Carcinoma Progression by Activating the MAPK Signaling Pathway Through Targeting and Suppressing CDK4

open access: yesPhytotherapy Research, Volume 40, Issue 6, Page 3171-3189, June 2026.
Pedunculoside targets and suppresses CDK4; consequently, it activates the MAPK pathway and inhibits hepatocellular carcinoma progression. ABSTRACT Hepatocellular carcinoma (HCC) remains a major challenge in cancer prevention and treatment, highlighting the urgent need for effective and low‐toxicity anti‐HCC therapies. Recently, CDK4‐targeted inhibitors
Yang Zhou   +9 more
wiley   +1 more source

First Case of Acute Pleural Empyema Caused by Mediterraneibacter gnavus

open access: yesRespirology Case Reports, Volume 14, Issue 6, June 2026.
We report the first case of acute pleural empyema caused by Mediterraneibacter gnavus, a gut commensal organism, identified by anaerobic culture in combination with MALDI‐TOF mass spectrometry and 16S rRNA gene sequencing. This case suggests that M. gnavus can act as an opportunistic pathogen in patients with significant comorbidities and highlights ...
Masahiro Shirata, Michiko Tsuchiya
wiley   +1 more source

Nanobodies: A Promising Toolkit for Diagnostic Applications

open access: yesSmartMat, Volume 7, Issue 3, June 2026.
This review focuses on camelid‐derived nanobodies (VHHs) and explains how their small size and high stability support robust diagnostic design. Applications across ELISA, lateral flow assays, and PET/SPECT imaging are summarized, along with clinical progress such as caplacizumab.
Wei Wu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy